ESR1 and prostate carcinoma: Similar to the effects of quercetin in Calu‐3‐ALIs and PBECs, a mixture containing quercetin downregulated TMPRSS2 and other androgen‐responsive genes in prostate cancer cells,57 and quercetin acts as an antagonist of estrogen receptor‐mediated activities in HeLa cells.58